Home / Toll-like Receptor Agonists / Resiquimod

Resiquimod

Catalog #: 4536
2 Citations Datasheet
Catalog # Availability Size / Price Qty
4536/10
4536/50
Resiquimod | CAS No. 144875-48-9 | Toll-like Receptor Agonists
1 Image
Description: Toll-like receptor 7 (TLR7) agonist
Alternative Names: R 848

Chemical Name: 1-[4-Amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol

Purity: ≥98%

Product Details
Citations (2)
Supplemental Products
Reviews
Biological Activity Technical Data Background Product Datasheets Calculators

Biological Activity

Resiquimod is a toll-like receptor 7 (TLR7) agonist. Induces upregulation of IL-6, IL-12, IFN-γ and iNOS expression in mouse bone marrow-derived macrophages (BMMs). Inhibits RANKL-induced osteoclast differentiation in mouse BMMs and human peripheral blood monocytes. Also promotes the differentiation of MDSCs into macrophages and dendritic cells. Proinflammatory and antiviral.

Technical Data

M.Wt:
314.38
Formula:
C17H22N4O2
Solubility:
Soluble to 100 mM in DMSO and to 20 mM in ethanol
Purity:
≥98%
Storage:
Store at +4°C
CAS No:
144875-48-9

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.

Background References

  1. Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.
    Martins K, Steffens J, van Tongeren S, Wells J, Bergeron A, Dickson S, Dye J, Salazar A, Bavari S
    PLoS ONE, 2014;9(2):e89735.
  2. Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity.
    Derouazi M, Di Berardino-Besson W, Belnoue E, Hoepner S, Walther R, Benkhoucha M, Teta P, Dufour Y, Yacoub Maroun C, Salazar A, Martinvalet D, Dietrich P, Walker P
    Cancer Res, 2015;75(15):3020-31.
  3. Resiquimod, a TLR7/8 agonist, promotes differentiation of myeloid-derived suppressor cells into macrophages and dendritic cells.
    Lee et al.
    Arch.Pharm.Res., 2014;37:1234
  4. Imiquimod and resiquimod as novel immunomodulators.
    Dockrell and Kinghorn
    J.Antimicrob.Chemother., 2001;48:751
  5. R848, a toll-like receptor 7 agonist, inhibits osteoclast differentiation but not survival or bone-resorbing function of mature osteoclasts.
    Miyamoto et al.
    Cytotechnology., 2012;64:331
  6. Modulation of TH1 and Th2 cytokine production with the immune response modifiers, R-848 and imiq.
    Wagner et al.
    Cell Immunol., 1999;191:10

Product Datasheets

COA view current batch
Or select another batch:
View Batch
SDS

Citations for Resiquimod

The citations listed below are publications that use Tocris products. Selected citations for Resiquimod include:

2 Citations: Showing 1 - 2

  1. Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine.
    Authors: Ming Et al.
    Cell Discov  2022;8:10
  2. Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies.
    Authors: Yumi Et al.
    Front Oncol  2022;12:869078

FAQs

No product specific FAQs exist for this product, however you may

View all Small Molecule FAQs

Reviews for Resiquimod

There are currently no reviews for this product. Be the first to review Resiquimod and earn rewards!

Have you used Resiquimod?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review
Tocris Bioscience is the leading supplier of novel and exclusive tools for life science research with over 30 years' experience in the industry. Tocris is a Bio-Techne brand.